Evidence map›Paper›PMID 35565654›Full record

ArticleNutrients2022

Magnesium-to-Calcium Ratio and Mortality from COVID-19.

Fernando Guerrero-Romero, Moises Mercado, Martha Rodriguez-Moran, Claudia Ramírez-Renteria, Gerardo Martínez-Aguilar, Daniel Marrero-Rodríguez, Aldo Ferreira-Hermosillo, Luis E Simental-Mendía, Ilan Remba-Shapiro, Claudia I Gamboa-Gómez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Fernando Guerrero-RomeroBiomedical Research Unit, Instituto Mexicano del Seguro Social, Durango 34067, Mexico.ORCID 0000-0001-9636-9870
Moises MercadoResearch Unit in Endocrine Diseases, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0002-4748-9734
Martha Rodriguez-MoranBiomedical Research Unit, Instituto Mexicano del Seguro Social, Durango 34067, Mexico.
Claudia Ramírez-RenteriaResearch Unit in Endocrine Diseases, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0003-3025-8339
Gerardo Martínez-AguilarBiomedical Research Unit, Instituto Mexicano del Seguro Social, Durango 34067, Mexico.
Daniel Marrero-RodríguezResearch Unit in Endocrine Diseases, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0001-5311-6654
Aldo Ferreira-HermosilloResearch Unit in Endocrine Diseases, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0002-5159-9856
Luis E Simental-MendíaBiomedical Research Unit, Instituto Mexicano del Seguro Social, Durango 34067, Mexico.ORCID 0000-0002-3617-4921
Ilan Remba-ShapiroResearch Unit in Endocrine Diseases, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0002-5149-3680
Claudia I Gamboa-GómezBiomedical Research Unit, Instituto Mexicano del Seguro Social, Durango 34067, Mexico.ORCID 0000-0002-2815-9406
Alejandra Albarrán-SánchezDepartment of Internal Medicine, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.ORCID 0000-0003-2693-4031
Miriam L Sanchez-GarcíaResearch Unit in Endocrine Diseases, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
Mexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity, type 2 diabetes, arterial hypertension, decrease in immune response, cytokine storm, endothelial dysfunction, and arrhythmias, which are frequent in COVID-19 patients, are associated with hypomagnesemia. Given that cellular influx and efflux of magnesium and calcium involve the same transporters, we aimed to evaluate the association of serum magnesium-to-calcium ratio with mortality from severe COVID-19. The clinical and laboratory data of 1064 patients, aged 60.3 ± 15.7 years, and hospitalized by COVID-19 from March 2020 to July 2021 were analyzed. The data of 554 (52%) patients discharged per death were compared with the data of 510 (48%) patients discharged per recovery. The ROC curve showed that the best cut-off point of the magnesium-to-calcium ratio for identifying individuals at high risk of mortality from COVID-19 was 0.20. The sensitivity and specificity were 83% and 24%. The adjusted multivariate regression model showed that the odds ratio between the magnesium-to-calcium ratio ≤0.20 and discharge per death from COVID-19 was 6.93 (

Indexed as

COVID-19Diabetes Mellitus, Type 2CalciumFemaleHumansMagnesiumMaleRetrospective StudiesROC CurveCalciumMagnesiumCOVID-19magnesium-to-calcium ratiomortality

Identifiers

PMID35565654
PMCPMC9101802
OpenAlexW4224263526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.